Atea Pharmaceuticals Inc at William Blair Biotech Focus Conference (Virtual) Transcript
Good afternoon or good morning, depending on which time zone you are joining us from. I am Tim Lugo. I am the Head of Biotech Research here at William Blair. I'm based in San Francisco, so I'm still enjoying my coffee this morning. And it is my pleasure this morning to welcome the team from Atea Pharmaceuticals.
Atea is an emerging antiviral drug developer. And most important for the Company and really the focus, most of the questions I get and maybe just important for global health in general is AT-527, which the Company is developing for COVID-19, along with partner Roche. They recently had some impressive results, which I'm sure we will dig into later.
I should note before we start our Q&A with our compliance, we would like to remind everyone to check williamblair.com for any disclosures. So with that, it is my pleasure to welcome the team, and JP, maybe you can discuss Atea briefly, your focus at the Company before we dig into a lot of the nuts and bolts of what you're working on.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
